JPRN-UMIN000026640已完成未知
Predictive factors associated with virological response in Ombitasvir/Paritaprevir/Ritonavir/Ribavirin combination therapy for genotype2a infected chronic hepatitis C patients - Virological response in Ombitasvir/Paritaprevir/Ritonavir/Ribavirin combination therapy for genotype2a infected chronic hepatitis C patients
ipppon Medical School Chiba Hokusoh Hospital0 个研究点目标入组 98 人开始时间: 2017年3月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 98
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1History of allergy to Ombitasvir/Paritaprevir /Ritonavir/Ribavirin 2Liver cirrhosis 3Patients with creatinine clearance less than 50 ml / min 4Pregnant woman or lactating mother 5Hepatocellular carcinoma, or other malignant tumor 6Judged by investigator not to be appropriate for inclusion in this study
研究者
相似试验
已完成
不适用
Predictive factors associated with virological response in Daclatasvir and Asunaprevir combination therapy for genotype1b-infected chronic hepatitis C patients : multicenter studyChronic hepatitis CJPRN-UMIN000017149ippon Medical School Chiba Hokusoh Hospital300
已完成
不适用
A Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Participants With Hepatitis CHepatitis C, ChronicNCT01659567Hoffmann-La Roche516
Unknown
不适用
Very Rapid and Rapid Virological Response as Predictors of Response of HCV TretmentPredictors of Response to HCV TretmentNCT03480269Assiut University100
尚未招募
不适用
To identify if there are any clinical or immunological markers that can help us predict disease relapse in a patient. This knowledge can help the physicians to decide when to administer the maintenance treatment to prevent clinical relapse.CTRI/2020/10/028675All India Institute of Medical Sciences
已完成
2 期
A Study of Disease Progression and Anti-HIV TreatmentsHIV InfectionsNCT00001068National Institute of Allergy and Infectious Diseases (NIAID)210